why choose us

First received: April 26, 2024

Clinical Trial: A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pain

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multiple-dose Escalation Study Evaluating the Safety and Pharmacokinetics of Intravenous VX-993 in Healthy Adults

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of intravenously administered VX-993 at different doses in healthy participants.

Read more